img

Global Eosinophilic Esophagitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Eosinophilic Esophagitis Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.
Eosinophilic Esophagitis Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Eosinophilic Esophagitis Drug market is projected to reach US$ 189.7 million in 2034, increasing from US$ 129.8 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Eosinophilic Esophagitis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
Segment by Type
Budesonide
Fluticasone
Others

Segment by Application


Hospitals
Clinics
Drugstore

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Eosinophilic Esophagitis Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Eosinophilic Esophagitis Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Eosinophilic Esophagitis Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Eosinophilic Esophagitis Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Eosinophilic Esophagitis Drug introduction, etc. Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Eosinophilic Esophagitis Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Eosinophilic Esophagitis Drug Market Overview
1.1 Eosinophilic Esophagitis Drug Product Overview
1.2 Eosinophilic Esophagitis Drug Market Segment by Type
1.2.1 Budesonide
1.2.2 Fluticasone
1.2.3 Others
1.3 Global Eosinophilic Esophagitis Drug Market Size by Type
1.3.1 Global Eosinophilic Esophagitis Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Eosinophilic Esophagitis Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Type (2018-2024)
2 Global Eosinophilic Esophagitis Drug Market Competition by Company
2.1 Global Top Players by Eosinophilic Esophagitis Drug Sales (2018-2024)
2.2 Global Top Players by Eosinophilic Esophagitis Drug Revenue (2018-2024)
2.3 Global Top Players by Eosinophilic Esophagitis Drug Price (2018-2024)
2.4 Global Top Manufacturers Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Eosinophilic Esophagitis Drug Market Competitive Situation and Trends
2.5.1 Eosinophilic Esophagitis Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Eosinophilic Esophagitis Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Eosinophilic Esophagitis Drug Market
2.8 Key Manufacturers Eosinophilic Esophagitis Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Eosinophilic Esophagitis Drug Status and Outlook by Region
3.1 Global Eosinophilic Esophagitis Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Eosinophilic Esophagitis Drug Historic Market Size by Region
3.2.1 Global Eosinophilic Esophagitis Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Eosinophilic Esophagitis Drug Sales in Value by Region (2018-2024)
3.2.3 Global Eosinophilic Esophagitis Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Region
3.3.1 Global Eosinophilic Esophagitis Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Eosinophilic Esophagitis Drug Sales in Value by Region (2024-2034)
3.3.3 Global Eosinophilic Esophagitis Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Eosinophilic Esophagitis Drug by Application
4.1 Eosinophilic Esophagitis Drug Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Drugstore
4.2 Global Eosinophilic Esophagitis Drug Market Size by Application
4.2.1 Global Eosinophilic Esophagitis Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Eosinophilic Esophagitis Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Eosinophilic Esophagitis Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Application (2018-2024)
5 North America Eosinophilic Esophagitis Drug by Country
5.1 North America Eosinophilic Esophagitis Drug Historic Market Size by Country
5.1.1 North America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Eosinophilic Esophagitis Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Eosinophilic Esophagitis Drug Sales in Value by Country (2018-2024)
5.2 North America Eosinophilic Esophagitis Drug Forecasted Market Size by Country
5.2.1 North America Eosinophilic Esophagitis Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Eosinophilic Esophagitis Drug Sales in Value by Country (2024-2034)
6 Europe Eosinophilic Esophagitis Drug by Country
6.1 Europe Eosinophilic Esophagitis Drug Historic Market Size by Country
6.1.1 Europe Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Eosinophilic Esophagitis Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Eosinophilic Esophagitis Drug Sales in Value by Country (2018-2024)
6.2 Europe Eosinophilic Esophagitis Drug Forecasted Market Size by Country
6.2.1 Europe Eosinophilic Esophagitis Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Eosinophilic Esophagitis Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Eosinophilic Esophagitis Drug by Region
7.1 Asia-Pacific Eosinophilic Esophagitis Drug Historic Market Size by Region
7.1.1 Asia-Pacific Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Eosinophilic Esophagitis Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Eosinophilic Esophagitis Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Eosinophilic Esophagitis Drug Sales in Value by Region (2024-2034)
8 Latin America Eosinophilic Esophagitis Drug by Country
8.1 Latin America Eosinophilic Esophagitis Drug Historic Market Size by Country
8.1.1 Latin America Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Eosinophilic Esophagitis Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Eosinophilic Esophagitis Drug Sales in Value by Country (2018-2024)
8.2 Latin America Eosinophilic Esophagitis Drug Forecasted Market Size by Country
8.2.1 Latin America Eosinophilic Esophagitis Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Eosinophilic Esophagitis Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Eosinophilic Esophagitis Drug by Country
9.1 Middle East and Africa Eosinophilic Esophagitis Drug Historic Market Size by Country
9.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Eosinophilic Esophagitis Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Eosinophilic Esophagitis Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
10.1.5 AstraZeneca Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
10.2.5 GSK Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
10.3.5 Bayer Recent Development
10.4 Adare Pharmaceuticals
10.4.1 Adare Pharmaceuticals Company Information
10.4.2 Adare Pharmaceuticals Introduction and Business Overview
10.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
10.4.5 Adare Pharmaceuticals Recent Development
10.5 DBV Technologies
10.5.1 DBV Technologies Company Information
10.5.2 DBV Technologies Introduction and Business Overview
10.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
10.5.5 DBV Technologies Recent Development
10.6 Dr. Falk Pharma
10.6.1 Dr. Falk Pharma Company Information
10.6.2 Dr. Falk Pharma Introduction and Business Overview
10.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
10.6.5 Dr. Falk Pharma Recent Development
10.7 Quorum Innovations
10.7.1 Quorum Innovations Company Information
10.7.2 Quorum Innovations Introduction and Business Overview
10.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
10.7.5 Quorum Innovations Recent Development
10.8 Takeda
10.8.1 Takeda Company Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
10.8.5 Takeda Recent Development
10.9 Calypso
10.9.1 Calypso Company Information
10.9.2 Calypso Introduction and Business Overview
10.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
10.9.5 Calypso Recent Development
10.10 Celgene
10.10.1 Celgene Company Information
10.10.2 Celgene Introduction and Business Overview
10.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
10.10.5 Celgene Recent Development
10.11 Regeneron
10.11.1 Regeneron Company Information
10.11.2 Regeneron Introduction and Business Overview
10.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Regeneron Eosinophilic Esophagitis Drug Products Offered
10.11.5 Regeneron Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Eosinophilic Esophagitis Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Eosinophilic Esophagitis Drug Industrial Chain Analysis
11.4 Eosinophilic Esophagitis Drug Market Dynamics
11.4.1 Eosinophilic Esophagitis Drug Industry Trends
11.4.2 Eosinophilic Esophagitis Drug Market Drivers
11.4.3 Eosinophilic Esophagitis Drug Market Challenges
11.4.4 Eosinophilic Esophagitis Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Eosinophilic Esophagitis Drug Distributors
12.3 Eosinophilic Esophagitis Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Budesonide
Table 2. Major Company of Fluticasone
Table 3. Major Company of Others
Table 4. Global Eosinophilic Esophagitis Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Eosinophilic Esophagitis Drug Market Share in Value by Type (2018-2024)
Table 9. Global Eosinophilic Esophagitis Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Eosinophilic Esophagitis Drug Sales by Type (2024-2034) & (K Units)
Table 11. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Eosinophilic Esophagitis Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Eosinophilic Esophagitis Drug Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Eosinophilic Esophagitis Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Eosinophilic Esophagitis Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Eosinophilic Esophagitis Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Eosinophilic Esophagitis Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Eosinophilic Esophagitis Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Eosinophilic Esophagitis Drug Sales Share by Company (2018-2024)
Table 27. Global Eosinophilic Esophagitis Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Eosinophilic Esophagitis Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Eosinophilic Esophagitis Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Eosinophilic Esophagitis Drug Market
Table 34. Key Manufacturers Eosinophilic Esophagitis Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Eosinophilic Esophagitis Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Eosinophilic Esophagitis Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Eosinophilic Esophagitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Eosinophilic Esophagitis Drug Sales by Region (2024-2034) & (K Units)
Table 43. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Eosinophilic Esophagitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Eosinophilic Esophagitis Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Eosinophilic Esophagitis Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Eosinophilic Esophagitis Drug Sales by Application (2024-2034) & (K Units)
Table 54. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Eosinophilic Esophagitis Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Eosinophilic Esophagitis Drug Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Eosinophilic Esophagitis Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Eosinophilic Esophagitis Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Eosinophilic Esophagitis Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (K Units)
Table 73. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (K Units)
Table 81. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Country (2024-2034)
Table 108. AstraZeneca Company Information
Table 109. AstraZeneca Introduction and Business Overview
Table 110. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 112. AstraZeneca Recent Development
Table 113. GSK Company Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. GSK Eosinophilic Esophagitis Drug Product
Table 117. GSK Recent Development
Table 118. Bayer Company Information
Table 119. Bayer Introduction and Business Overview
Table 120. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Bayer Eosinophilic Esophagitis Drug Product
Table 122. Bayer Recent Development
Table 123. Adare Pharmaceuticals Company Information
Table 124. Adare Pharmaceuticals Introduction and Business Overview
Table 125. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 127. Adare Pharmaceuticals Recent Development
Table 128. DBV Technologies Company Information
Table 129. DBV Technologies Introduction and Business Overview
Table 130. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 132. DBV Technologies Recent Development
Table 133. Dr. Falk Pharma Company Information
Table 134. Dr. Falk Pharma Introduction and Business Overview
Table 135. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 137. Dr. Falk Pharma Recent Development
Table 138. Quorum Innovations Company Information
Table 139. Quorum Innovations Introduction and Business Overview
Table 140. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 142. Quorum Innovations Recent Development
Table 143. Takeda Company Information
Table 144. Takeda Introduction and Business Overview
Table 145. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Takeda Eosinophilic Esophagitis Drug Product
Table 147. Takeda Recent Development
Table 148. Calypso Company Information
Table 149. Calypso Introduction and Business Overview
Table 150. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Calypso Eosinophilic Esophagitis Drug Product
Table 152. Calypso Recent Development
Table 153. Celgene Company Information
Table 154. Celgene Introduction and Business Overview
Table 155. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Celgene Eosinophilic Esophagitis Drug Product
Table 157. Celgene Recent Development
Table 158. Regeneron Company Information
Table 159. Regeneron Introduction and Business Overview
Table 160. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Regeneron Eosinophilic Esophagitis Drug Product
Table 162. Regeneron Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Eosinophilic Esophagitis Drug Market Trends
Table 166. Eosinophilic Esophagitis Drug Market Drivers
Table 167. Eosinophilic Esophagitis Drug Market Challenges
Table 168. Eosinophilic Esophagitis Drug Market Restraints
Table 169. Eosinophilic Esophagitis Drug Distributors List
Table 170. Eosinophilic Esophagitis Drug Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Eosinophilic Esophagitis Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Eosinophilic Esophagitis Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Budesonide
Figure 6. Global Budesonide Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Fluticasone
Figure 8. Global Fluticasone Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Eosinophilic Esophagitis Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Esophagitis Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Esophagitis Drug Revenue in 2022
Figure 25. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Clinics
Figure 29. Global Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Drugstore
Figure 31. Global Drugstore Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Eosinophilic Esophagitis Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Eosinophilic Esophagitis Drug Manufacturing Cost Structure
Figure 45. Eosinophilic Esophagitis Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries